AzTrials
AzTrials

SatietyNCT07204470

The Effects of Four Instant Maize Porridges on Satiety Measures

A study testing Breakfast cereal standardised to an isocaloric intake of approximately 350 kcal, consume entire portion within 15 minutes witnessed. No other food may be consumed during the 4 hour test period. in people with Satiety, run by PepsiCo Global R&D at 1 site in South Africa.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study is designed to test the hypothesis that whole-grain forms of maize meal enhance and prolong satiety post-meal consumption. Read more about this study

Who is it for?
Ages 18 to 35 yearsHealthy volunteers can take part
Conditions the study is for
Satiety
What is being tested?
Breakfast cereal standardised to an isocaloric intake of approximately 350 kcal, consume entire portion within 15 minutes witnessed. No other food may be consumed during the 4 hour test period.
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteSouth Africa
Study dates
21 Jul 2025to 15 Aug 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 35 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Availability to participate on the test days
  • Interest and consent to participate in the study
  • Participants must be willing to fast 10 hours overnight before the test breakfast meal (only water allowed)
  • Products and meals high in fiber, alcohol and strenuous exercise should be avoided 24 hours before the test
  • Age 18-35 years
  • Healthy BMI: 18.5-24.9 kg/m2
  • Equal split, males and females

Who cannot join

  • Pregnancy; breast-feeding
  • History of gastrointestinal disease having an impact on food absorption or digestion; anorexia nervosa or bulimia nervosa
  • Anaemia
  • Hypoglycaemia
  • Cardiovascular disease; elevated plasma glucose; unstable thyroid function
  • Abnormal/irregular menstrual cycle
Show all 13Show fewer
  • Substance abuse
  • Being on medication which influences appetite
  • Depression; smoking
  • Participation in any weight altering program; weight gain or loss > 5 kg in 3 months prior to enrolment
  • History of intestinal discomfort when consuming relatively small (e.g., <10g) amounts of non-digestible fibres
  • Any known food allergies or intolerances such as wheat or soy; special diets prescribed by medical practitioner
  • Any intensive physical training program

Trial locations and contacts

1 site in 1 country.

South Africa1 site
  • U. Pretoria

    Pretoria, 0083

Other trials in South Africa

About this study

This study is designed to test the hypothesis that whole-grain forms of maize meal enhance and prolong satiety post-meal consumption.

Conditions
Satiety
Being tested
Breakfast cereal standardised to an isocaloric intake of approximately 350 kcal, consume entire portion within 15 minutes witnessed. No other food may be consumed during the 4 hour test period.
Keywords
whole grain, appetite, glycemic index, leptin, ghrelin

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Breakfast cereal standardised to an isocaloric intake of approximately 350 kcal, consume entire portion within 15 minutes witnessed. No other food may be consumed during the 4 hour test period.Other

    Cereal is in porridge form. One 350 ml bottle of water provided for the 4 hour test period 7:00-11:00 a.m.. Control dinner meal consumed the prior evening, then fast 10 hours overnight before visiting the test facility on four test days one week apart.

Study groups in NCT07204470
Study groupRoleWhat they receive
Whole grain maize porridge prepared with cold waterExperimentalWhite Star Whole Grain Instant Maize Porridge Original
Receives: Other: Breakfast cereal standardised to an isocaloric intake of approximately 350 kcal, consume entire portion within 15 minutes witnessed. No other food may be consumed during the 4 hour test period.
Whole grain maize porridge prepared with hot waterExperimentalWhite Star Whole Grain Instant Maize Porridge Original
Receives: Other: Breakfast cereal standardised to an isocaloric intake of approximately 350 kcal, consume entire portion within 15 minutes witnessed. No other food may be consumed during the 4 hour test period.
Smart FoodExperimentalFUTURELIFE Smart Food Original
Receives: Other: Breakfast cereal standardised to an isocaloric intake of approximately 350 kcal, consume entire portion within 15 minutes witnessed. No other food may be consumed during the 4 hour test period.
Instant Maize Porridge - reduced sugar formulation (WSIP)ExperimentalWhite Star Instant Maize Porridge Original- reduced sugar formulation (WSIP)
Receives: Other: Breakfast cereal standardised to an isocaloric intake of approximately 350 kcal, consume entire portion within 15 minutes witnessed. No other food may be consumed during the 4 hour test period.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Satiety -Appetite

    Self-reported appetite ratings using a 100 mm visual analog scale (VAS) questionnaire with 3 items: desire to eat rated from very weak to very strong, hunger rated from not at all to extremely, and fullness rated from not at all to extremely.

    Measured: On each of four testing days, in fasted state, immediately after the standardised breakfast (0), and at 120 and 240 min after the breakfast

  2. Satiety -Biomarkers: Leptin

    Blood by venipuncture to measure the appetite-regulating hormone leptin in nanograms per milliliter

    Measured: On each of four test days at baseline following a 10 hour fast (Time 0), at 2 hours and 4 hours post ingestion of test porridge

  3. Satiety -Biomarkers: Ghrelin

    Blood by venipuncture to measure the appetite-regulating hormone ghrelin in picograms per milliliter

    Measured: On each of four test days at baseline following a 10 hour fast (Time 0), at 2 hours and 4 hours post ingestion of test porridge

  4. Satiety - glycaemic parameters: Glucose

    Blood samples obtained by venipuncture in millimoles per liter

    Measured: On each of four test days at baseline following a 10 hour fast (Time 0), at 2 hours and 4 hours post ingestion of test porridge

  5. Satiety - glycaemic parameters: Insulin

    Serum samples obtained by venipuncture in microunits per milliliter

    Measured: On each of four test days at baseline following a 10 hour fast (Time 0), at 2 hours and 4 hours post ingestion of test porridge

Secondary outcomes (5)
  1. Anthropometric measurements - BMI

    Body mass index calculated from kg weight and cm height

    Measured: Test Day 1 only prior to porridge consumption

  2. Anthropometric measurements - WHR

    Waist-hip ratio in centimeters

    Measured: Test Day 1 only prior to porridge consumption

  3. Anthropometric measurements - Fat Mass

    Body composition measurement

    Measured: Test Day 1 only prior to porridge consumption

  4. Dietary intake habits-QFFQ

    Interviewer-administered, completed once using a quantified food frequency questionnaire (QFFQ) of 140 typically consumed food items by type/brand, cooking methods, frequency, and the amount of all food and drink consumed in the past 4 weeks converted to grams per week per food item

    Measured: The protocol allows for completion prior to the first test day, or instead at any one of the four test days. There is no particular time point requirement that it be done at baseline nor within a certain window after test meal consumption.

  5. Dietary intake habits-24 hour recall

    Using a quantified food frequency questionnaire (QFFQ)

    Measured: Completed at each of the four test days. There is no particular time point requirement that it be done at baseline nor within a certain window after test meal consumption.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Oct 2025
  2. Study start21 Jul 2025
  3. Primary completion15 Aug 2025
  4. Study completion15 Aug 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
50 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07204470
Sponsor's protocol ID
PEP-2410
Status last verified
Apr 2026
First submitted
17 Sep 2025
Last updated
21 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Breakfast cereal standardised to an isocaloric intake of approximately 350 kcal, consume entire portion within 15 minutes witnessed. No other food may be consumed during the 4 hour test period. in people with Satiety, run by PepsiCo Global R&D at 1 site in South Africa.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Africa. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Satiety -Appetite (time frame: On each of four testing days, in fasted state, immediately after the standardised breakfast (0), and at 120 and 240 min after the breakfast). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in